Schistosomiasis project gets $1.15M boost from Gates Foundation

08/26/2013 | Pharmaceutical Business Review Online

An international public-private partnership that aims to develop a pediatric treatment for schistosomiasis, or bilharzia, received a $1.15 million grant from the Bill & Melinda Gates Foundation. Members of the consortium include Astellas Pharma, Merck KGaA and the Swiss Tropical and Public Health Institute.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID